Bezalip Mono, known generically as bezafibrate, is a medication primarily used in the management of hyperlipidemia, a condition characterized by elevated levels of lipids or fats in the blood. It belongs to the class of drugs known as fibrates, which work by activating peroxisome proliferator-activated receptors (PPARs) in the body. This activation leads to an increase in the breakdown of lipids and a decrease in the production of triglycerides, thereby lowering the levels of triglycerides and increasing the levels of high-density lipoprotein (HDL) cholesterol in the blood. Bezalip Mono is often prescribed when diet, exercise, and weight loss have not been enough to reduce blood lipid levels to a desired range. It is important for patients to follow their healthcare provider's instructions closely when taking Bezalip Mono, including adhering to any recommended dietary guidelines.